These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18567128)

  • 41. A cardiovascular benefit of ophthalmic beta-blockade.
    Easton PJ
    Age Ageing; 2007 May; 36(3):351. PubMed ID: 17405778
    [No Abstract]   [Full Text] [Related]  

  • 42. Beta-blockers for migraine.
    Evans RW; Rizzoli P; Loder E; Bana D
    Headache; 2008 Mar; 48(3):455-60. PubMed ID: 18302703
    [No Abstract]   [Full Text] [Related]  

  • 43. Timolol Eyedrops in the Treatment of Acute Migraine Attacks: A Randomized Crossover Study.
    Cossack M; Nabrinsky E; Turner H; Abraham A; Gratton S
    JAMA Neurol; 2018 Aug; 75(8):1024-1025. PubMed ID: 29799915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Migraine treatment in children].
    Pothmann R
    Dtsch Med Wochenschr; 1993 Feb; 118(6):202. PubMed ID: 8094665
    [No Abstract]   [Full Text] [Related]  

  • 45. [Beta-adrenergic inhibitors and migraine].
    Dubois B; Bousser MG
    Therapie; 1985; 40(6):407-12. PubMed ID: 2868536
    [No Abstract]   [Full Text] [Related]  

  • 46. Topical estrogen drops for glaucoma? A long way to go.
    Yin H; Liu X
    Med Hypotheses; 2008; 70(5):1069. PubMed ID: 18178012
    [No Abstract]   [Full Text] [Related]  

  • 47. Conjunctival damage induced by long-term topical anti-glaucoma therapy.
    Broadway D; Hitchings R
    Acta Ophthalmol Scand; 1996 Feb; 74(1):97. PubMed ID: 8689495
    [No Abstract]   [Full Text] [Related]  

  • 48. Drop size of ocular carteolol hydrochloride.
    Sorensen SJ; Abel SR
    Am J Hosp Pharm; 1994 Jun; 51(11):1470, 1473. PubMed ID: 7942881
    [No Abstract]   [Full Text] [Related]  

  • 49. [Drugs in migraine. I. Preventive treatment].
    Naess K
    Sykepleien; 1981 Jun; 68(11):16-8. PubMed ID: 6116292
    [No Abstract]   [Full Text] [Related]  

  • 50. Answering the Call: A Prospective Look at the Role of Timolol Eye Drops in the Treatment of Acute Migraine Attacks.
    Gratton S; Cossack M
    Mo Med; 2018; 115(6):520-521. PubMed ID: 30643343
    [No Abstract]   [Full Text] [Related]  

  • 51. [Basic treatment of migraine].
    Raphael M
    Soins Psychiatr; 1988; (94-95):I-II. PubMed ID: 2903560
    [No Abstract]   [Full Text] [Related]  

  • 52. Are drops the solution? A eureka moment? Beta blocker eye drops for acute migraines.
    Hagan JC
    Mo Med; 2014; 111(4):280-1. PubMed ID: 25211850
    [No Abstract]   [Full Text] [Related]  

  • 53. [Understanding the treatment of migraine].
    De Léan J
    Union Med Can; 1995 Nov; 124(3):40-8. PubMed ID: 8560638
    [No Abstract]   [Full Text] [Related]  

  • 54. [Indications for beta-receptor blockaders in psychiatry].
    Benkert O
    Internist (Berl); 1978 Sep; 19(9):542-6. PubMed ID: 29854
    [No Abstract]   [Full Text] [Related]  

  • 55. Introduction: new insights on enhancing adherence to topical glaucoma medications.
    Friedman DS
    Ophthalmology; 2009 Nov; 116(11 Suppl):S29. PubMed ID: 19837257
    [No Abstract]   [Full Text] [Related]  

  • 56. [Beta blockers in the treatment of neurological disorders].
    Kostić VS
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():54-8. PubMed ID: 18193812
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intracerebral penetration of carteolol hydrochloride in rats.
    Kudo S; Umehara K; Abe Y; Furukawa M; Odomi M
    Psychopharmacology (Berl); 1997 Jun; 131(4):388-93. PubMed ID: 9226741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bending the rule of monotherapy for migraine prevention?
    Evans RW; Pascual J; Láinez MJ; Leira R
    Headache; 2005 Jun; 45(6):748-50. PubMed ID: 15953308
    [No Abstract]   [Full Text] [Related]  

  • 59. Glaucoma therapy: implications for the internist.
    Rockwood EJ
    Cleve Clin J Med; 1995; 62(1):10-1. PubMed ID: 7859396
    [No Abstract]   [Full Text] [Related]  

  • 60. Allergic contact dermatitis due to levobunolol in an ophthalmic preparation.
    Hashimoto Y; Aragane Y; Kawada A
    J Dermatol; 2006 Jul; 33(7):507-9. PubMed ID: 16848829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.